Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Stress-enhanced cardiac lncRNA Morrbid protects hearts from acute myocardial infarction
Yang Yu, Haiqiong Yang, Qiuting Li, Nianhui Ding, Jiali Gao, Gan Qiao, Jianguo Feng, Xin Zhang, Jianming Wu, Yajun Yu, Xiangyu Zhou, Xiaobin Wang, Chunxiang Zhang
Yang Yu, Haiqiong Yang, Qiuting Li, Nianhui Ding, Jiali Gao, Gan Qiao, Jianguo Feng, Xin Zhang, Jianming Wu, Yajun Yu, Xiangyu Zhou, Xiaobin Wang, Chunxiang Zhang
View: Text | PDF
Research Article Cardiology Cell biology

Stress-enhanced cardiac lncRNA Morrbid protects hearts from acute myocardial infarction

  • Text
  • PDF
Abstract

Myeloid RNA regulator of Bim-induced death (Morrbid) is a newly identified leukocyte-specific long noncoding RNA (lncRNA). However, the expression and biological functions of Morrbid in cardiomyocytes and heart disease are currently unclear. This study was meant to determine the role of cardiac Morrbid in acute myocardial infarction (AMI) and to identify the potential cellular and molecular mechanisms involved. We found that both human and mouse cardiomyocytes could express a significant amount of Morrbid and that its expression was increased in cardiomyocytes with hypoxia or oxidative stress as well as in mouse hearts with AMI. Overexpression of Morrbid reduced the myocardial infarct size and cardiac dysfunction, whereas the infarct size and cardiac dysfunction deteriorated in cardiomyocyte-specific Morrbid-KO (Morrbidfl/fl/Myh6-Cre) mice. We identified that Morrbid had a protective effect against hypoxia- or H2O2-induced apoptosis; this was also confirmed in vivo in mouse hearts after AMI. We further discovered that serpine1 was a direct target gene of Morrbid that was involved in the Morrbid-mediated protective effect on cardiomyocytes. In summary, we have found, for the first time to our knowledge, that the cardiac Morrbid is a stress-enhanced lncRNA that protects hearts from AMI via antiapoptosis through its target gene serpine1. Morrbid may be a novel promising therapeutic target for ischemic heart diseases such as AMI.

Authors

Yang Yu, Haiqiong Yang, Qiuting Li, Nianhui Ding, Jiali Gao, Gan Qiao, Jianguo Feng, Xin Zhang, Jianming Wu, Yajun Yu, Xiangyu Zhou, Xiaobin Wang, Chunxiang Zhang

×

Figure 5

The expression relationship between Morrbid and serpine1 mRNA.

Options: View larger image (or click on image) Download as PowerPoint
The expression relationship between Morrbid and serpine1 mRNA.
(A and B)...
(A and B) Computational analysis indicates that serpine1 mRNA has binding sites with both human and mouse Morrbid. (C) The expression of serpine1 mRNA in mouse hearts at 24 hours after AMI was increased (P < 0.001; Sham, n = 7; AMI, n = 7). (D) The expression of serpine1 mRNA in cultured NMCM with hypoxia for 24 hours was increased (P < 0.001; Control, n = 6; Hypoxia, n = 5). (E) The expression of serpine1 mRNA in cultured NMCM treated with H2O2 (50 μM) for 12 hours was increased (P < 0.001; Control, n = 5; H2O2, n = 4). (F) The expression of serpine1 mRNA in cultured HCMs with hypoxia for 48 hours was increased (P < 0.001; Control, n = 6; Hypoxia, n = 5). (G) The expression of serpine1 mRNA in the Ad-Morrbid–treated mouse hearts was increased (P = 0.0014, Ad-GFP, n = 7; Ad-Morrbid, n = 5). (H) The expression of serpine1 mRNA in cardiomyocyte-specific Morrbid-KO mouse hearts was decreased (P < 0.001, Morrbidfl/fl, n = 6; Morrbidfl/fl/Myh6-Cre, n = 5). (I) The expression of serpine1 mRNA in the Ad-Morrbid–treated HCMs was increased (P = 0.0015, Ad-GFP, n = 4; Ad-Morrbid, n = 4), whereas Ad-Morrbid siRNA–treated (Ad-Morrbid-Si–treated) HCMs decreased the expression of serpine1mRNA (P = 0.0021, Ad-GFP, n = 4; Ad-Morrbid siRNA, n = 4). Thus, Morrbid positively regulated the expression of serpine1 mRNA. **P < 0.01; ***P < 0.001 by unpaired 2-tailed Student’s t tests (C–H) or 1-way ANOVA with Sidak’s post hoc correction for multiple comparisons (I).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts